Results 191 to 200 of about 513,484 (358)
Combining immunotherapy with radiation therapy in thoracic oncology [PDF]
Badiyan, Shahed N+9 more
core +1 more source
This work reports a nanoplasmonic biosensing platform with exceptional surface sensitivity (0.618 nm nm−1, Δn = 0.117 nmol) and narrow linewidth (≈20 nm) under normal incidence. By integrating a miscellaneous‐protein strategy with initial rate analysis (IRA), this sensor can detect 1 ng mL−1 of AFP in serum with a broad linear range (1–104 ng mL−1 ...
Yi Liu+6 more
wiley +1 more source
Uncertainty estimation for dosimetry in radiation oncology. [PDF]
Lechner W, Palmans H.
europepmc +1 more source
Toward the year 2000 Seventh annual meeting society for radiation oncology administrators
openalex +1 more source
A Phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207) [PDF]
Laurie E. Gaspar+5 more
openalex +1 more source
Herpes Simplex Virus Type 1 (HSV‐1) infection triggers metabolic reprogramming in corneal cells, shifting from mitochondrial respiration to aerobic glycolysis with marked upregulation of Hexokinase‐2 (HK2). This study identifies HK2 as a therapeutic target: inhibiting HK2 with lonidamine significantly reduces viral replication and promotes corneal ...
Dan Jiang+9 more
wiley +1 more source
Current and Future Developments in Radiation Oncology Approach for Rhabdomyosarcoma. [PDF]
Dávila Fajardo R+4 more
europepmc +1 more source
STK25 Loss Augments Anti‐PD‐1 Therapy Efficacy by Regulating PD‐L1 Stability in Colorectal Cancer
This study demonstrates that STK25 depletion facilitates CRC immune escape through the inhibition of PD‐L1 Ser283 phosphorylation‐mediated ubiquitination, and promotes tumor growth. Furthermore, these findings identify STK25 as a potential therapeutic target to trigger antitumor immunity and promote immunotherapy efficacy. Abstract Tumor immune evasion
Xiaowen Qiao+20 more
wiley +1 more source